Cargando…
Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan
Gene-based vaccines as typified by plasmid DNA vaccines and recombinant viral-vectored vaccines are expected as promising solutions against infectious diseases for which no effective prophylactic vaccines exist such as HIV, dengue virus, Ebola virus and malaria, and for which more improved vaccines...
Autores principales: | Nakayama, Yoshikazu, Aruga, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494244/ https://www.ncbi.nlm.nih.gov/pubmed/26344953 http://dx.doi.org/10.3390/vaccines3010186 |
Ejemplares similares
-
Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.
por: Trows, Sabrina, et al.
Publicado: (2014) -
To vaccinate or not to vaccinate!? Predictors of willingness to receive Covid-19 vaccination in Europe, the U.S., and China
por: Brailovskaia, Julia, et al.
Publicado: (2021) -
Europe pulls ahead of U.S. in physics
Publicado: (2008) -
Public Debt Dynamics of Europe and the U.S
por: Chorafas, Dimitris
Publicado: (2013) -
Europe 3, U.S. not even Z-Zero
Publicado: (1983)